FDA product code JND: Nadp Reduction, 6-Phosphogluconate Dehydrogenase
JND is the FDA product code for nadp reduction, 6-phosphogluconate dehydrogenase. It is a Class I device, regulated under 21 CFR 862.1565 and reviewed by the Clinical Chemistry panel. Devices under JND reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Nadp Reduction, 6-Phosphogluconate Dehydrogenase |
| Device class | Class I |
| Regulation | 21 CFR 862.1565 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) exempt |
Recalls for JND devices
openFDA lists no recalls for product code JND.
Frequently asked questions
What is FDA product code JND?
JND is the FDA product code for nadp reduction, 6-phosphogluconate dehydrogenase. It is a Class I device, regulated under 21 CFR 862.1565 and reviewed by the Clinical Chemistry panel.
What device class is JND?
Class I, regulation 21 CFR 862.1565. Typical premarket route: 510(k) exempt.
Next steps
- Run an FDA pathway report with predicate devices for product code JND
- Run a recall and safety report across every JND manufacturer
- Watch product code JND for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times